FDA Approves Eli Lilly’s GLP-1 Pill April 1, 2026 Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy. Related posts: Exposed DeepSeek Database Revealed Chat Prompts and Internal Data Identities of More Than 80 Americans Stolen for North Korean IT Worker Scams Looking to Buy a Window Air Conditioner? Read This First Brendan Carr Wants to Make All of Trump’s ‘Fake News’ Retribution Dreams Come True Post navigation Previous Previous post: Nativists Loom Over SCOTUS Birthright Citizenship Arguments Next Next post: World’s oldest known tortoise, Jonathan, dies aged 193 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Notify me of follow-up comments by email. Notify me of new posts by email. Related News Michael ‘The Hero’ Dawodu Steals the Spotlight as Benard, Uduak Shine at Abuja MMA Showdown April 27, 2026 Lume Cube Edge Light Go Review (2026): Versatile, Portable April 23, 2026
